Filter
1047
Filtered Results: 1047
Text search:
Antigen
testing
Featured
Recommendations
148
New Publications
277
Language
Document type
No document type
556
Guidelines
224
Studies & Reports
114
Manuals
54
Fact sheets
39
Strategic & Response Plan
33
Training Material
9
Situation Updates
6
Resource Platforms
4
Online Courses
3
Brochures
2
Infographics
2
Videos
1
Countries / Regions
India
64
Global
32
Germany
31
South Africa
26
Africa
24
Kenya
23
Nigeria
23
Tanzania
21
Western and Central Europe
21
Sierra Leone
16
Uganda
15
Philippines
14
East and Southern Africa
14
Zambia
14
Liberia
14
Nepal
13
Rwanda
13
Malawi
13
Ukraine
12
Ghana
12
West and Central Africa
12
Ethiopia
12
Russia
11
Latin America and the Carribbean
10
Namibia
10
Zimbabwe
9
Congo, Democratic Republic of
8
Bangladesh
8
Indonesia
8
Myanmar / Burma
8
Middle East and North Africa
7
South–East Asia Region
6
Eastern Europe and Central Asia
6
Lesotho
5
Syria
5
Brazil
5
Mozambique
4
USA
4
Cambodia
4
Eastern Europe
4
Colombia
3
Cameroon
3
Albania
3
Asia
3
Saudi Arabia
3
Sudan
3
Botswana
3
South Sudan
3
Pakistan
3
Iran
2
Burkina Faso
2
Afghanistan
2
Guinea
2
Jordan
2
Lebanon
2
Angola
2
Libya
2
Iraq
2
Somalia
2
Eswatini/ Swaziland
2
North Macedonia
1
Timor Leste/ East Timor
1
China
1
Kazakhstan
1
Chile
1
Peru
1
Morocco
1
Qatar
1
Haiti
1
Western Pacific Region
1
North America
1
Tunisia
1
United Kingdom
1
Spain
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Central African Republic
1
Mali
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
400
Clinical Guidelines
153
Pharmacy & Technologies
49
Public Health
35
Women & Child Health
22
Key Resources
21
Capacity Building
12
Toolboxes
COVID-19
188
HIV
134
TB
85
Rapid Response
61
NTDs
56
Ebola
40
Refugee
25
Pharmacy
18
AMR
13
Zika
12
Caregiver
10
Conflict
10
Mental Health
9
Polio
8
Cholera
7
Planetary Health
6
Natural Hazards
5
NCDs
5
Health Financing Toolbox
3
Global Health Education
3
Specific Hazards
1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон,
принимающих участие в диагностической работе для выявлен...
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b...
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe...
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
(Last Update: July 2022)
